WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

Afraa Zrieki*

ABSTRACT

The objective of this study was to assess the relationship between treatment efficacy, and treatment satisfaction in patients on stable medication regimens for type 2 diabetes. Diabetes Treatment Satisfaction Questionnaire (DTSQ) was used to evaluate the treatment satisfaction in 515 T2DM patients. Treatment Efficacy was evaluated by comparing the glycosylated hemoglobin (HbA1c) values and the percentage of patients who achieved the glycemic control (HbA1c<7%). The relationship between DTSQ score and other socio-demographics and clinical variables was also evaluated. Only 33.7 % of patients have HbA1c<7%. A good glycemic control was observed in patients treated with sulfonylurea (mean HbA1c = 6.5±2.1%), the combination of metformin with SGLT2 inhibitors (mean HbA1c =6.6±1.4%), and the combination of metformin with sulfonylurea and SGLT2I with (6.9±3.4%) or without DPP4I (6.9±2.1%).The mean HbA1c value exceeded 7% in all other patterns of treatment. All patients in sulfonylurea group as well as in Metf+Sulf+SGLT2 group had (HbA1c<7%). Best DTSQ score was observed in patients treated with sulfonylurea (21.28±5.77) followed by that observed in patient treated with Metf+SGLT2 inhibitors (20.77±5.27). Patients with a higher DTSQ score had a lower associated HbA1c measurement (P<0.01). Presence of diabetic foot ulcer associated with significantly lower DTSQ score (P=0.038), while adherence to physical activity more than 3 times a week associated with higher DTSQ (P=0.017). In conclusion, the DTSQ score may be an efficient tool for identifying patients with poor treatment satisfaction who can then be targeted for interventions to promote glycemic control.

[Full Text Article] [Download Certificate]